Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM8Y1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,073
Award facts
- Contract value 100% obligated
- $16,072.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,072.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 15 mg/0.5 mL pen injections. The contract, with an ultimate completion date of January 7, 2026, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. This award was not set-aside and was competitively awarded, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract supports military healthcare supply needs as part of the broader pharmaceutical supply chain managed by the Defense Logistics Agency's Medical Supply operations.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive product portfolio. The company's extensive IDC with DLA Troop Support Medical encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes treatment medication, demonstrates the contractor's ongoing role in fulfilling essential pharmaceutical requirements for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FM8Y1?
SPE2DR26FM8Y1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FM8Y1 worth?
The government has obligated $16,073 on SPE2DR26FM8Y1.
Is contract SPE2DR26FM8Y1 an order under another contract?
Yes. SPE2DR26FM8Y1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8Y1 competed?
The extent of competition for SPE2DR26FM8Y1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award